Literature DB >> 821466

A study of the physicochemical interactions between biliary lipids and chlorpromazine hydrochloride. Bile-salt precipitation as a mechanism of phenothiazine-induced bile secretory failure.

M C Carey, P C Hirom, D M Small.   

Abstract

Since chlorpromazine hydrochloride [2-chloro-10-(3-dimethylaminopropyl)-phenothiazine hydrochloride] is commonly implicated in causing bile-secretory failure in man and is secreted into bile, we have studied the physicochemical interactions of the drug with the major components of bile in vitro. Chlorpromazine hydrochloride molecules are amphiphilic by virtue of possessing a polar tertiary amine group linked by a short paraffin chain to a tricyclic hydrophobic part. At pH values below the apparent pK (pK'a 7.4) the molecules are water-soluble cationic detergents. We show that bile salts in concentrations above their critical micellar concentrations are precipitated from solution by chlorpromazine hydrochloride as insoluble 1:1 salt complexes. In the case of mixed bile-salt/phosphatidylcholine micellar solutions, however, the degree of precipitation is inhibited by the phospholipid in proportion to its mole fraction. With increases in the concentration of chlorpromazine hydrochloride or bile salt, micellar solubilization of the precipitated complexes results. Sonicated dispersions of the negatively charged phospholipid phosphatidylserine were also precipitated, but dispersions of the zwitterionic phospholipid phosphatidylcholine were not. Chlorpromazine hydrochloride efficiently solubilized these membrane phospholipids as mixed micellar solutions when the drug:phospholipid molar ratio reached 4:1. Polarizing-microscopy and X-ray-diffraction studies revealed that the precipitated complexes were amorphous and potentiometric studies confirmed the presence of a salt bond. Some dissociation of the complex occurred in the case of the most polar bile salt (Ks 0.365). As canalicular bile-salt secretion determines much of bile-water flow, we propose that complexing and precipitation of bile salts by chlorpromazine hydrochloride and its metabolites may be physicochemically related to the reversible bile-secretory failure produced by this drug.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 821466      PMCID: PMC1172618          DOI: 10.1042/bj1530519

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  40 in total

1.  INTERACTIONS BETWEEN ORANGE II AND SELECTED LONG CHAIN QUATERNARY AMMONIUM SALTS.

Authors:  G ZOGRAFI; P R PATEL; N D WEINER
Journal:  J Pharm Sci       Date:  1964-05       Impact factor: 3.534

2.  THE BINDING OF POLYPHOSPHATES BY PHENOTHIAZINES AND RELATED COMPOUNDS: A POSSIBLE RELATIONSHIP TO CLINICAL POTENCY AS TRANQUILISERS.

Authors:  P HELE
Journal:  Biochem Pharmacol       Date:  1964-08       Impact factor: 5.858

3.  HEPATIC SECRETION AND URINARY EXCRETION OF THREE S35-LABELED PHENOTHIAZINES IN THE DOG.

Authors:  E J VANLOON; T L FLANAGAN; W J NOVICK; A R MAASS
Journal:  J Pharm Sci       Date:  1964-10       Impact factor: 3.534

4.  Effect of chlorpromazine, chlordiazepoxide, diazepam and chlorprothixene on bile and intrabillary pressure in cholecystectomized dogs.

Authors:  P L STEFKO; G ZBINDEN
Journal:  Am J Gastroenterol       Date:  1963-04       Impact factor: 10.864

5.  Distribution of phenothiazines in tissue.

Authors:  J B RAGLAND
Journal:  Psychopharmacol Serv Cent Bull       Date:  1962-12

6.  Liver cell necrosis in chlorpromazine jaundice (allergic cholangiolitis). A serial study of twenty-six needle biopsy specimens in nine patients.

Authors:  S ZELMAN
Journal:  Am J Med       Date:  1959-11       Impact factor: 4.965

7.  Complex formation of chlorpromazine with flavins.

Authors:  K YAGI; T OZAWA; T NAGATSU
Journal:  Nature       Date:  1959-09-26       Impact factor: 49.962

8.  Spectrophotometric method for the determination of chlorpromazine and chlorpromazine sulphoxide in biological fluids.

Authors:  T L FLANAGAN; T H LIN; W J NOVICK; I M RONDISH; C A BOCHER; E J VAN LOON
Journal:  J Med Pharm Chem       Date:  1959-06

9.  Drug-induced hepatic injury.

Authors:  H POPPER; F SCHAFFNER
Journal:  Ann Intern Med       Date:  1959-12       Impact factor: 25.391

10.  Biliary stasis produced by chlorpromazine: an experimental study.

Authors:  R B MENGUY; J L ROLLMAN; J H GRINDLAY; J B CAIN
Journal:  Proc Staff Meet Mayo Clin       Date:  1955-12-14
View more
  7 in total

1.  The effects of amphiphilic cationic drugs and inorganic cations on the activity of phosphatidate phosphohydrolase.

Authors:  M Bowley; J Cooling; S L Burditt; D N Brindley
Journal:  Biochem J       Date:  1977-09-01       Impact factor: 3.857

2.  Cholestasis.

Authors: 
Journal:  West J Med       Date:  1983-02

3.  Self-association of unconjugated bilirubin-IX alpha in aqueous solution at pH 10.0 and physical-chemical interactions with bile salt monomers and micelles.

Authors:  M C Carey; A P Koretsky
Journal:  Biochem J       Date:  1979-06-01       Impact factor: 3.857

4.  Ionization and solubilization of 4 alkyl benzoic acids and 4 alkyl anilines in sodium taurodeoxycholate solutions.

Authors:  T S Wiedmann; K Kvanbeck; C H Han; V Roongta
Journal:  Pharm Res       Date:  1997-11       Impact factor: 4.200

Review 5.  Drug-induced cholestasis.

Authors:  H J Zimmerman; J H Lewis
Journal:  Med Toxicol       Date:  1987 Mar-Apr

6.  Incorporation of chlorpromazine into bilayer liposomes for protection against microsomal metabolism and liver absorption.

Authors:  R A Schwendener
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1988 Apr-Jun       Impact factor: 2.441

Review 7.  The effect of drugs on bile flow and composition. An overview.

Authors:  L Okolicsanyi; F Lirussi; M Strazzabosco; R M Jemmolo; R Orlando; G Nassuato; M Muraca; G Crepaldi
Journal:  Drugs       Date:  1986-05       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.